Product Image

CircuForce

HealthForce SuperFoods
4.5
★ ★ ★ ★ ★
(269 ratings)
Eleuthero 125 mg
Ginkgo
Product Image
Score70
A coherent three-herb cognitive blend with transparent weights, but no active-marker standardization and one clearly mismatched prior vision summary.
How scoring works
Quantity:90 Vegan Cap(s) • (90 servings)
Goals:
Vision Support
Productivity Boost
Cognitive Support
Brain Health

Score 70

A coherent three-herb cognitive blend with transparent weights, but no active-marker standardization and one clearly mismatched prior vision summary.
How scoring works
$33.95($0.37 per serving)
Amazon
$ 44.95
Pure Formulas
$ 44.95
Vitacost
$ 39.95
iHerb
$ 33.95
Report prices

Analysis

Ginkgo at 250 mg provides the main circulation-based cognitive rationale, while 125 mg each of eleuthero and gotu kola broaden the stress-resilience and traditional cognitive profile. The formula is more thoughtfully focused than a large proprietary blend.

All ingredient weights are disclosed, but no flavonglycoside, terpene-lactone, eleutheroside, or gotu-kola marker standardization is stated. Milligrams therefore show formula balance without confirming consistent extract strength.

The product best fits adults seeking a multi-botanical cognitive capsule rather than a single standardized ginkgo extract. It should not be chosen for the unrelated astaxanthin claims present in one supplied score summary, because astaxanthin is not listed among the ingredients.

Who is it for
  • Adults seeking a multi-herb cognitive formula
  • People interested in circulation and stress-resilience support
Best for
  • Broad botanical cognitive support
  • A vegan capsule with individually disclosed ingredients

Pros

  • Provides 250 mg of ginkgo extract
  • Includes eleuthero root and gotu kola
  • Discloses every ingredient amount
  • Uses a focused three-herb formula

Cons

  • No active-marker standardization is shown
  • Ginkgo purity limits are absent
  • Companion botanicals are modest
  • One supplied vision summary does not match the ingredient list

Warnings

  • Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines and around surgery.

Nutrient quality

74 High impact

A substantial ginkgo amount leads a coherent three-botanical formula. Missing active-marker standardization for every extract limits potency assurance.

.

Ingredient transparency

74 High impact

All botanical amounts are disclosed without a hidden blend. Intake directions, inactive ingredients, and extract ratios are not supplied.

.

Customer satisfaction

62 Moderate impact

The supplied average rating is strong and comes from a limited rating pool. No firsthand experiences or recurring complaint details were provided, so consistency remains uncertain.

.

Value for money

64 Moderate impact

The focused blend and substantial ginkgo amount provide moderate value. Absent standardization makes the serving cost harder to justify confidently.

.
Report analysis

Goals

Vision Support
Impact
Highest effect
B+ Goal FitA+ Strength of SupportC- CoverageA+ Formula Quality

Natural astaxanthin provides targeted retinal antioxidant support and may help eye strain linked to prolonged screen use. Human evidence is promising for visual fatigue but less comprehensive than multi-nutrient macular formulas.

The algae source and substantial amount are clearly disclosed in a fat-containing softgel. The focused formula offers strong antioxidant depth but does not cover macular pigments, minerals, or omega fatty acids.

Productivity Boost
Impact
High effect
B Goal FitC+ Strength of SupportB- CoverageA- Formula Quality
Eleuthero · 125 mgEleuthero · 125 mg

Ginkgo, eleuthero, and gotu kola combine cerebral circulation with stress and fatigue support. Evidence is most useful for standardized ginkgo and selected adaptogen outcomes, while this product provides limited extract detail.

The ginkgo amount is substantial, but eleuthero and gotu kola are more modest and none has marker standardization. Ginkgo may increase bleeding risk with anticoagulant or antiplatelet medicines, especially around surgery.

Study evidence
Eleuthero No effect 1 study
Eleuthero Not classified

No linked studies yet.

Ginkgo Supportive 20 studies
Ginkgo Supportive 12 studies
Cognitive Support
Impact
High effect
B Goal FitC Strength of SupportB- CoverageA- Formula Quality

Ginkgo targets cerebral circulation, while eleuthero may support mental stamina during stress and gotu kola adds traditional cognitive support. The three disclosed extracts create broader cognitive coverage than a single-herb product.

Missing active-marker standardization limits confidence in ginkgo and eleuthero potency. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Eleuthero No effect 1 study
Ginkgo Supportive 87 studies
Brain Health
Impact
High effect
B Goal FitD+ Strength of SupportB- CoverageB+ Formula Quality

Ginkgo, eleuthero, and gotu kola provide a plausible mix of cerebral circulation and stress-resilience support. The exact amounts are individually stated.

None of the botanical extracts show active-marker standardization, limiting confidence in potency. Ginkgo may raise bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 90 studies
Mental Focus
Impact
Moderate effect
C- Goal FitC- Strength of SupportC CoverageB Formula Quality

Ginkgo, eleuthero, and gotu kola offer a reasonable combination of circulation, stress resilience, and cognitive support. Human focus evidence is mixed, and none of the extracts includes active-marker standardization.

The ginkgo amount is near common extract use and eleuthero reaches a modest supportive amount. Ginkgo may increase bleeding risk when taken with anticoagulant or antiplatelet medicines.

Study evidence
Eleuthero Disputed 3 studies
Ginkgo Supportive 28 studies

Ingredients

IngredientAmount per serving
Ginkgo biloba leaf extract
250 mg
Eleuthero root extract
125 mg
Gotu Kola whole herb extract
125 mg
Gluten Free Adults 18–50 Vegan Kosher Organic Vegetarian
Report overview
Eleuthero · 125 mg OverallScore66
D Active Ingredient Quality & BioavailabilityB Dose, Safety & Label TransparencyB+ Value

The formula provides a clearly labeled 125 mg Eleuthero root extract in a convenient single capsule. Its dose reaches the minimum useful extract threshold but falls below the more substantial targeted range. Missing eleutheroside standardization limits confidence in potency, while the cost remains favorable for the disclosed amount.

Ginkgo · 250 mg OverallScore33
F Active Ingredient Quality & BioavailabilityB- Dose, Safety & Label TransparencyF Value

The standalone ginkgo extract amount is clearly disclosed and sits close to the commonly used daily range. Missing active-marker standardization and ginkgolic acid testing make potency, purity, and value difficult to confirm. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Ginkgo biloba for cognitive impairment and dementia.
    Wieland LS; Ludeman E; Chi Y; Feinberg TM; Chen IH; Chen KH; Zhu Y; Wolverson E; Amri H · The Cochrane database of systematic reviews · 2026
    Meta-analysis10,613 participants82 studies pooledCognitive Support forGinkgo
  2. Ginkgo biloba Extract (EGb761), Cholinesterase Inhibitors, and Memantine for the Treatment of Mild-to-Moderate Alzheimer's Disease: A Network Meta-Analysis.
    Thancharoen O; Limwattananon C; Waleekhachonloet O; Rattanachotphanit T; Limwattananon P; Limpawattana P · Drugs & aging · 2019
    Meta-analysisCognitive Support forGinkgo
  3. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
    Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L · Journal of Alzheimer's disease : JAD · 2015
    Meta-analysis2,561 participants9 studies pooledCognitive Support Brain Health forGinkgo
  4. Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
    von Gunten A; Schlaefke S; Überla K · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2017
    Meta-analysis1,628 participants4 studies pooledCognitive Support Brain Health forGinkgo
  5. Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
    Tian X; Xu Q; Xia X; Zhang Y; Meng X; Wang A · Journal of neurology · 2024
    Randomized trial3,163 participantsCognitive Support forGinkgo
  6. Meta-analysis of the efficacy and safety of Ginkgo biloba extract for the treatment of dementia.
    Hashiguchi M; Ohta Y; Shimizu M; Maruyama J; Mochizuki M · Journal of pharmaceutical health care and sciences · 2016
    Meta-analysis2,381 participants13 studies pooledCognitive Support forGinkgo
  7. Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
    Riepe M; Hoerr R; Schlaefke S · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2025
    Meta-analysis782 participants4 studies pooledCognitive Support Brain Health Productivity Boost forGinkgo
  8. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
    Le Bars PL; Katz MM; Berman N; Itil TM; Freedman AM; Schatzberg AF · JAMA · 1997
    Randomized trial309 participantsCognitive Support Productivity Boost forGinkgo
  9. Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
    Bachinskaya N; Hoerr R; Ihl R · Neuropsychiatric disease and treatment · 2011
    Randomized trial410 participantsCognitive Support forGinkgo
  10. EGb in the Treatment for Patients with VCI: A Systematic Review and Meta-Analysis.
    Zhan M; Sun L; Liu J; Zeng Z; Shen W; Li H; Wang Y; Han F; Shi J; Zeng X; Lu X; Zhang Y; Liao X · Oxidative medicine and cellular longevity · 2022
    Meta-analysis2,019 participants23 studies pooledCognitive Support forGinkgo
  11. Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
    Cui M; You T; Zhao Y; Liu R; Guan Y; Liu J; Liu X; Wang X; Dong Q · Frontiers in pharmacology · 2023
    Randomized trial201 participantsBrain Health Productivity Boost forGinkgo
  12. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
    Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S · Journal of psychiatric research · 2012
    Randomized trial410 participantsBrain Health forGinkgo
  13. No benefit adding eleutherococcus senticosus to stress management training in stress-related fatigue/weakness, impaired work or concentration, a randomized controlled study.
    Schaffler K; Wolf OT; Burkart M · Pharmacopsychiatry · 2014
    Randomized trial144 participantsCognitive Support Mental Focus Productivity Boost forEleuthero
  14. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
    Ihl R; Bachinskaya N; Korczyn AD; Vakhapova V; Tribanek M; Hoerr R; Napryeyenko O; GOTADAY Study Group · International journal of geriatric psychiatry · 2013
    Randomized trial410 participantsCognitive Support forGinkgo
  15. Evidence-based efficacy of adaptogens in fatigue, and molecular mechanisms related to their stress-protective activity.
    Panossian A; Wikman G · Current clinical pharmacology · 2009
    Narrative reviewMental Focus forEleuthero
  16. Stimulating effect of adaptogens: an overview with particular reference to their efficacy following single dose administration.
    Panossian A; Wagner H · Phytotherapy research : PTR · 2005
    Narrative reviewMental Focus forEleuthero
  17. Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
    Hort J; Duning T; Hoerr R · Neuropsychiatric disease and treatment · 2023
    Systematic review946 participants9 studies pooledMental Focus forGinkgo
  18. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2012
    Randomized trial216 participantsMental Focus forGinkgo
  19. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Pharmacopsychiatry · 1996
    Randomized trial216 participantsMental Focus forGinkgo
  20. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
    Li S; Zhang X; Fang Q; Zhou J; Zhang M; Wang H; Chen Y; Xu B; Wu Y; Qian L; Xu Y · Stroke and vascular neurology · 2021
    Randomized trial348 participantsMental Focus forGinkgo
  21. Ginkgo biloba in the Aging Process: A Narrative Review.
    Barbalho SM; Direito R; Laurindo LF; Marton LT; Guiguer EL; Goulart RA; Tofano RJ; Carvalho ACA; Flato UAP; Capelluppi Tofano VA; Detregiachi CRP; Bueno PCS; Girio RSJ; Araújo AC · Antioxidants (Basel, Switzerland) · 2024
    Narrative review14 studies pooledMental Focus forGinkgo
  22. [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].
    Kasper S; Schubert H · Fortschritte der Neurologie-Psychiatrie · 2009
    Meta-analysis10 studies pooledProductivity Boost forGinkgo
  23. Dietary Flavonoids and Human Cognition: A Meta-Analysis.
    Cheng N; Bell L; Lamport DJ; Williams CM · Molecular nutrition & food research · 2022
    Meta-analysis5,519 participants80 studies pooledProductivity Boost forGinkgo
  24. Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba.
    Elsabagh S; Hartley DE; File SE · Journal of psychopharmacology (Oxford, England) · 2005
    Randomized trial87 participantsProductivity Boost forGinkgo
  25. Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial.
    Gavrilova SI; Preuss UW; Wong JW; Hoerr R; Kaschel R; Bachinskaya N; GIMCIPlus Study Group · International journal of geriatric psychiatry · 2015
    Randomized trial160 participantsProductivity Boost forGinkgo
  26. Modulation of cognitive performance following single doses of 120 mg Ginkgo biloba extract administered to healthy young volunteers.
    Kennedy DO; Jackson PA; Haskell CF; Scholey AB · Human psychopharmacology · 2008
    Randomized trial78 participantsProductivity Boost forGinkgo